22.02.2010 • News

Schlumberger, Smith Don't See Antitrust Sales

Schlumberger and Smith International do not expect to have to sell any major assets to get antitrust clearance for the oilfield services leader's acquisition of Smith, a source familiar with the deal said on Sunday.

Schlumberger earlier on Sunday announced a deal to buy Smith in an all-stock deal that values the company at about $11.3 billion. Commenting after the Wall Street Journal reported on Friday that Schlumberger was in talks to buy Smith, analysts said government antitrust enforcers could give the deal a hard look.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read